Breaking News Instant updates and real-time market news.

LDR

Landauer

09:10
11/28/16
11/28
09:10
11/28/16
09:10

Gilead 'extremely disappointed,' see running slate of Landauer directors

Gilead Capital in a regulatory filing says it is "extremely disappointed" with the response provided by Landauer "filed within just a few hours" of the firm's sending an open letter to the board on November 22. The board's actions and the private letter sent "are wholly inadequate and not only fail to address the Reporting Persons' concerns but exacerbate them," Gilead Capital writes. It adds, "The Reporting Persons are dismayed that Executive Chairman Michael Leatherman remains on the Board and that the Board intends to nominate him for re-election as a director, though not as Executive Chairman, at the 2017 annual meeting of stockholders...The Reporting Persons are alarmed by the Board's determination in the Private Letter that Mr. Leatherman's misrepresentation of his credentials is 'not material' despite the fact that, (i) as interim CFO and a member of the Audit Committee, he presided over the preparation of the 2011 to 2014 financial statements of the Issuer that ultimately needed restatement or revision, and (ii) as an individual with no prior industry experience relevant to radiation measurement, the Board held out Mr. Leatherman's CPA status as a material qualification for his election as a director...The Reporting Persons have privately informed the Issuer of its grave concerns with the response and reiterated that Mr. Leatherman should be removed as a director and officer immediately. In light of the Form 8-K response, the Private Letter, and the apparent ongoing refusal to publicly and transparently address the governance concerns raised by the Reporting Persons, the Reporting Persons believe the Board has failed to place the best interests of stockholders ahead of the personal interests of insiders. Accordingly, the Reporting Persons believe they are left with no alternative but to run a slate of directors in opposition to the Board's nominees at the 2017 Annual Meeting."

LDR Landauer

07/01/16
HDLY
07/01/16
DOWNGRADE
HDLY
Underperform
Landauer downgraded to Underperform from Neutral at Hilliard Lyons
Hilliard Lyons analyst Kurt Kemper downgraded Landauer to Underperform citing market share erosion and pricing pressures.
08/16/16
SIDC
08/16/16
DOWNGRADE
Target $52
SIDC
Neutral
Landauer downgraded to Neutral from Buy at Sidoti
Sidoti downgraded Landauer citing valuation and maintained its $52 price target. .

TODAY'S FREE FLY STORIES

GTY

Getty Realty

$25.05

0.21 (0.85%)

08:11
06/27/17
06/27
08:11
06/27/17
08:11
Hot Stocks
Getty Realty enters definitive agreement to acquire 49 properties for $123M »

Getty Realty announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XENE

Xenon Pharmaceuticals

$3.80

-0.3 (-7.32%)

08:10
06/27/17
06/27
08:10
06/27/17
08:10
Hot Stocks
Breaking Hot Stocks news story on Xenon Pharmaceuticals »

Xenon Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABIL

Ability

$1.40

0.14 (11.11%)

08:09
06/27/17
06/27
08:09
06/27/17
08:09
Hot Stocks
Ability regains Nasdaq listing compliance »

Ability received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCYT

Veracyte

$7.90

0.14 (1.80%)

08:09
06/27/17
06/27
08:09
06/27/17
08:09
Hot Stocks
Veracyte says study published supporting Envisia Genomic Classifier »

Veracyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$53.74

-0.59 (-1.09%)

08:08
06/27/17
06/27
08:08
06/27/17
08:08
Recommendations
PayPal analyst commentary  »

PayPal could free up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

RCII

Rent-A-Center

$11.48

0.28 (2.50%)

08:08
06/27/17
06/27
08:08
06/27/17
08:08
Hot Stocks
Rent-A-Center names Martin Evans chief human resources officer »

Rent-A-Center announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$248.91

2.45 (0.99%)

08:07
06/27/17
06/27
08:07
06/27/17
08:07
Hot Stocks
Allergan launches Refresh Optive Mega-3 artificial tears »

Allergan launched the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSTG

Biostage

$0.34

0.025 (7.94%)

08:07
06/27/17
06/27
08:07
06/27/17
08:07
Syndicate
Biostage raises $3.1M in a private placement »

Biostage announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBVX

MabVax Therapeutics

$1.46

-0.0775 (-5.04%)

08:06
06/27/17
06/27
08:06
06/27/17
08:06
Hot Stocks
MabVax Therapeutics begins dosing in Phase 1 clinical trial evaluating MVT-1075 »

MabVax Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPLD

Upland Software

$22.29

-0.21 (-0.93%)

08:06
06/27/17
06/27
08:06
06/27/17
08:06
Initiation
Upland Software initiated  »

Upland Software initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVIV

InVivo Therapeutics

$2.55

-0.3 (-10.53%)

08:05
06/27/17
06/27
08:05
06/27/17
08:05
Hot Stocks
InVivo Therapeutics announces new patient enrollment in INSPIRE study »

InVivo Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

PHG

Philips

$36.74

-0.12 (-0.33%)

08:04
06/27/17
06/27
08:04
06/27/17
08:04
Hot Stocks
Philips receives FDA 510(k) clearance to market IntelliSpace Portal 9.0 »

Royal Philips announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$90.08

1.35 (1.52%)

08:03
06/27/17
06/27
08:03
06/27/17
08:03
Technical Analysis
Technical View: Darden trades near 52-week high after earnings »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 18

    Jul

  • 19

    Jul

KSS

Kohl's

$37.52

0.49 (1.32%)

, SVU

Supervalu

$3.03

0.09 (3.06%)

08:03
06/27/17
06/27
08:03
06/27/17
08:03
Hot Stocks
Kohl's appoints Bruce Besanko as CFO »

Kohl's (KSS)…

KSS

Kohl's

$37.52

0.49 (1.32%)

SVU

Supervalu

$3.03

0.09 (3.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$65.92

-0.24 (-0.36%)

, SNY

Sanofi

$49.59

0.26 (0.53%)

08:03
06/27/17
06/27
08:03
06/27/17
08:03
Recommendations
Merck, Sanofi, Johnson & Johnson, Bristol-Myers, Pfizer, Roche, Novartis, AstraZeneca, GlaxoSmithKline, Eli Lilly analyst commentary  »

Large cap pharma could…

MRK

Merck

$65.92

-0.24 (-0.36%)

SNY

Sanofi

$49.59

0.26 (0.53%)

JNJ

Johnson & Johnson

$136.34

-0.09 (-0.07%)

BMY

Bristol-Myers

$56.92

0.28 (0.49%)

PFE

Pfizer

$34.04

-0.13 (-0.38%)

RHHBY

Roche

$32.47

-0.29 (-0.89%)

NVS

Novartis

$85.75

-0.59 (-0.68%)

AZN

AstraZeneca

$35.15

0.08 (0.23%)

GSK

GlaxoSmithKline

$44.07

-0.22 (-0.50%)

LLY

Eli Lilly

$84.28

0.39 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 11

    Jul

  • 12

    Jul

  • 13

    Jul

  • 18

    Jul

  • 27

    Jul

  • 30

    Jul

  • 02

    Aug

  • 27

    Aug

  • 22

    Sep

  • 24

    Sep

NFEC

NF Energy

$0.92

0.01 (1.10%)

08:02
06/27/17
06/27
08:02
06/27/17
08:02
Hot Stocks
NF Energy signs $600K valve sales contract »

NF Energy signed a $600K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROV

Trovagene

$1.12

-0.02 (-1.75%)

08:02
06/27/17
06/27
08:02
06/27/17
08:02
Hot Stocks
Trovagene submits IND application to FDA for Phase 1b/2 trial of PCM-075 »

Trovagene announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWKS

Skyworks

$101.32

-3.04 (-2.91%)

08:00
06/27/17
06/27
08:00
06/27/17
08:00
Options
Skyworks put buyer realizes 14% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHAK

Shake Shack

$35.54

-1.46 (-3.95%)

07:59
06/27/17
06/27
07:59
06/27/17
07:59
Recommendations
Shake Shack analyst commentary  »

Shake Shack Q2 comps may…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MON

Monsanto

$117.80

0.78 (0.67%)

, BAYRY

Bayer

$136.70

0.34 (0.25%)

07:56
06/27/17
06/27
07:56
06/27/17
07:56
Downgrade
Monsanto, Bayer rating change  »

Monsanto downgraded to…

MON

Monsanto

$117.80

0.78 (0.67%)

BAYRY

Bayer

$136.70

0.34 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

07:55
06/27/17
06/27
07:55
06/27/17
07:55
General news
U.S. chain store sales climbed 2.9% in the week ended June 24 »

U.S. chain store sales…

RARX

RA Pharmaceuticals

$22.18

-0.83 (-3.61%)

07:55
06/27/17
06/27
07:55
06/27/17
07:55
Conference/Events
RA Pharmaceuticals to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

WDC

Western Digital

$92.66

-0.68 (-0.73%)

07:54
06/27/17
06/27
07:54
06/27/17
07:54
Recommendations
Western Digital analyst commentary  »

Morgan Stanley has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$515.91

-1.42 (-0.27%)

07:53
06/27/17
06/27
07:53
06/27/17
07:53
Recommendations
Regeneron analyst commentary  »

Regeneron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FARM

Farmer Bros.

$30.75

0.7 (2.33%)

07:50
06/27/17
06/27
07:50
06/27/17
07:50
Conference/Events
Farmer Bros. management to meet with B. Riley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.